CCR5 Receptor Antagonists
-
Subject Areas on Research
- A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis.
- Acute graft-versus-host disease: are we close to bringing the bench to the bedside?
- Chemokine receptors and human immunodeficiency virus infection.
- Genotypic analysis of the V3 region of HIV from virologic nonresponders to maraviroc-containing regimens reveals distinct patterns of failure.
- HIV entry inhibitors: progress in development and application.
- HIV-1 resistance to CCR5 antagonists associated with highly efficient use of CCR5 and altered tropism on primary CD4+ T cells.
- High-resolution, noninvasive longitudinal live imaging of immune responses.
- Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector.
- Isolation and structure of antagonists of chemokine receptor (CCR5).
- Reliable genotypic tropism tests for the major HIV-1 subtypes.
- Tyrosine-sulfate isosteres of CCR5 N-terminus as tools for studying HIV-1 entry.